ArticleFrontiers in pediatrics2026
Early lung ultrasound score combined with umbilical cord-blood procalcitonin improves 1-year prognostic stratification in preterm neonates with respiratory distress syndrome.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory distress syndrome (RDS) remains a major cause of morbidity in very preterm infants. Lung ultrasound score (LUS) provides a bedside assessment of lung aeration and has demonstrated utility for early respiratory decision-making, but its prognostic performance for long-term outcomes is only moderate. Procalcitonin (PCT) measured in umbilical cord blood may reflect perinatal inflammatory exposure and risk of infection-related complications. Methods: We conducted a single-center prospective cohort study enrolling infants born at 24 + 0-33 + 6 weeks' gestation who were admitted to the NICU within 6 h of birth and were clinically diagnosed with RDS. Within 6 h after delivery, a standardized 12-zone LUS and umbilical cord-blood PCT were obtained. The primary endpoint was a composite of bronchopulmonary dysplasia, severe intraventricular hemorrhage, necrotizing enterocolitis, culture-proven sepsis occurring after 72 h of age, or all-cause death within 12 months' corrected age. Discrimination was evaluated using ROC analysis and DeLong tests. Time-to-first-event associations were examined using multivariable Cox regression. Internal validation used bootstrap optimism correction. Results: Among 290 infants, 110 (37.9%) reached the composite endpoint (event-free proportion 62.1%). LUS alone achieved an AUC of 0.76 (95% CI 0.70-0.82), and PCT alone an AUC of 0.78 (0.72-0.84). A logistic model combining LUS and log-transformed PCT improved discrimination to an AUC of 0.87 (0.83-0.92), outperforming each single marker (paired DeLong Conclusions: In preterm infants with RDS, early integration of 12-zone LUS and cord-blood PCT improves prediction of 12-month major morbidity or death compared with either marker alone. This bedside approach may support early risk stratification. External validation and impact studies are needed before score-guided management is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.